Home
/ Unimed
/ Competitors

Unimed Competitors and Similar CompaniesClear all

Unimed's competitors and similar companies include Nipponflex, Southern Prosthetic Supplies, Zhejiang Gongdong Medical Technology and Richard Wolf.

	Unimed Unimed is a manufacturer of medical devices.	Nipponflex Nipponflex is a company that specializes in the development of the scientific sleeping system.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.
Founding Date	Founding Date 1958	Founding Date 1987	Founding Date 1951	Founding Date 1985	Founding Date 1906
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices
Locations	Locations Ecublens, CH HQ Lausanne, CH	Locations Maringá, BR HQ Aracaju, BR Brasilia, BR Cabedelo, BR Campo Grande, BR Contagem, BR Cuiabá, BR see more	Locations Alpharetta, US HQ Fresno, US	Locations Taizhou, CN HQ Riverside, US	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more
Employees	Employees 37	Employees 1,586	Employees 1981% increase	Employees 1,693	Employees 1,800
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥1.1b (FY, 2024)	Revenue (est.) €249.9m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥749.5m (FY, 2024)	Cost of goods €70.1m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥352.8m (FY, 2024)	Gross profit €179.7m (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ¥171.5m (FY, 2024)	Net income €4.1m (FY, 2021)